• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Dana Incorporated filed SEC Form 8-K: Financial Statements and Exhibits

    6/11/25 5:11:10 PM ET
    $DAN
    Auto Parts:O.E.M.
    Consumer Discretionary
    Get the next $DAN alert in real time by email
    FORM 8-K
    false 0000026780 0000026780 2025-06-11 2025-06-11 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    FORM 8-K

    CURRENT REPORT

    Pursuant to Section 13 or 15(d)

    of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): June 11, 2025

    Dana Incorporated

    (Exact name of registrant as specified in its charter)

    Delaware   1-1063   26-1531856
    (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification Number)

     

    3939 Technology Drive, Maumee, Ohio 43537
    (Address of principal executive offices) (Zip Code)
     
    (419) 887-3000
    (Registrant’s telephone number, including area code)

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

    Title of Each Class

     

    Trading
    Symbol

     

    Name of Each Exchange
    on which Registered

    Common Stock, $.01 par value   DAN   New York Stock Exchange

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     

    Items 2.02 and 7.01.           Results of Operations and Financial Condition and Regulation FD Disclosure.

    On June 11, 2025, Dana Incorporated (“Dana”) issued a press release announcing that (i) Dana has entered into a definitive agreement to sell its off-highway business to Allison Transmission Holdings, Inc. and (ii) the Dana board of directors has authorized a $1 billion capital return program through 2027. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.

    In connection with the proposed transaction, Dana intends to present and/or distribute to certain investors a slide presentation, which is attached to this report as Exhibit 99.2 and incorporated by reference herein (the “Investor Presentation”). The Investor Presentation contains certain information about Dana’s full-year guidance as well as supplemental information regarding the proposed transaction. Dana undertakes no obligation to update, supplement or amend the materials attached hereto as Exhibit 99.2. The Investor Presentation may also be used by executive management of Dana in future meetings with investors and analysts.

    The information in this report is being “furnished” and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, is not subject to the liabilities of that section and is not deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except as shall be expressly set forth by specific reference in such a filing.

    Item 9.01.Financial Statements and Exhibits.

     

    (d)       Exhibits. The following items are furnished with this report.

     

    Exhibit No.

     

    Description

    99.1   Dana Incorporated Press Release dated June 11, 2025
    99.2   Dana Incorporated Presentation dated June 12, 2025
    104   Cover Page Interactive Data File (embedded within the Inline XBRL)

     

      

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

           
      DANA INCORPORATED  
           

    Date: June 11, 2025

    By:

    /s/ Douglas H. Liedberg

     
      Name: Douglas H. Liedberg  
      Title: Senior Vice President, General Counsel and Secretary  

     

     

     

      

     

    Get the next $DAN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DAN

    DatePrice TargetRatingAnalyst
    5/22/2025$20.00Sector Perform → Outperform
    RBC Capital Mkts
    1/27/2025$10.00 → $16.00Underweight → Equal Weight
    Wells Fargo
    1/16/2025$11.00 → $18.00Neutral → Buy
    UBS
    12/9/2024$9.00 → $19.00Hold → Buy
    Deutsche Bank
    12/3/2024$9.00 → $16.00Neutral → Outperform
    Exane BNP Paribas
    12/2/2024$18.00Equal Weight → Overweight
    Barclays
    9/20/2024$13.00 → $9.00Equal Weight → Underweight
    Wells Fargo
    9/10/2024$12.00Hold
    Deutsche Bank
    More analyst ratings